Industry News: The First International Stem Cell Community DaySelectScience.net (press release) (registration)On April 4, 2017 the first international Stem Cell Community Day will take place in Hamburg. Experts from academia and industry will discuss t… Continue reading
Science Daily |
Deep Learning predicts hematopoietic stem cell development
Science Daily Scientists at the Helmholtz Zentrum München and their partners at ETH Zurich and the Technical University of Munich (TUM) have now used it to determine the development of hematopoietic stem cells in advance. In Nature Methods they describe how their … |
Genetic Literacy Project |
Fighting children’s diseases: Focus should be on gene therapy, not embryonic gene editing
Genetic Literacy Project Mendel’s laws, like any laws in science, are wonderful because they make predictions possible…If an observation seems to counter dogma, then we investigate and get to the truth. That’s what happened for Millie McWilliams and Hannah Sames, whose … |
Fox News |
BrainStorm seeks early approval for stem cell treatment in Canada
Fox News TEL AVIV – Israel’s BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes late-stage clinical trials. Brainstorm Cell Therapeutics (BCLI) Signs Agreement with CCRM to Support Market Authorization Request for …StreetInsider.com |
Phys.Org |
Deep learning predicts hematopoietic stem cell development
Phys.Org What are they going to be? Hematopoietic stem cells under the microscope: New methods are helping the Helmholtz scientists to predict how they will develop. Credit: Helmholtz Zentrum München. Autonomous driving, automatic speech recognition, and the … |
|
Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate
Yahoo Finance “The ability to control the intensity and duration of a cell-based treatment may help address the limitations that current CAR T therapies face, especially when targeting solid tumors. While our first study is in pancreatic cancer where there is great … |